Vaughn Himes
Director/Board Member at ACHIEVE LIFE SCIENCES, INC.
Net worth: - $ as of 31/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven Gillis | M | 71 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 30 years |
| Cindy Jacobs | M | 66 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 23 years |
| Athena Kartsaklis | F | 59 | 7 years | |
| Nell Beattie | F | 36 | 9 years | |
| John Bencich | M | 47 | 10 years | |
| Anthony Clarke | M | 68 | 9 years | |
| Jeff Baxter | M | 62 | 8 years | |
| Thomas King | M | 69 | 1 years | |
| Douglas Maffei | M | - | 4 years | |
| Thomas Sellig | M | 57 | 1 years | |
| Nicole Anderson | F | - | 7 years | |
| Misha Nossov | M | - | 14 years | |
| Joanne Cordeiro | F | 66 | 5 years | |
| Bridget Martell | M | 58 | 4 years | |
| Richard Stewart | M | 65 | 9 years | |
| Stuart Duty | M | 59 | 1 years | |
| Blaine McKee | M | 59 | 5 years | |
| Michel de Wilde | M | 74 | 8 years | |
| Damian Braga | M | 68 | 4 years | |
| Chris Boshoff | M | - | 1 years | |
| Natasha Hernday | F | 52 | 13 years | |
| John Dillman | M | 56 | 2 years | |
| David Caouette | M | - | 3 years | |
| David Anderson | M | 54 | 8 years | |
| Avi Mazaltov | M | 62 | 7 years | |
| T. Buckley | M | 48 | 23 years | |
| Francisco Diaz-Mitoma | M | 69 | 8 years | |
| Jaime Xinos | F | - | 7 years | |
| Sherry Pudloski | F | - | 1 years | |
| Alison Marquez O'Neill | F | - | 1 years | |
| Jerry Wan | M | 42 | 7 years | |
| Deborah Baron | F | 55 | 1 years | |
| Guy Padbury | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Clay Siegall | M | 63 | 25 years | |
| Todd Simpson | M | 63 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | 27 years |
| James Johnson | M | 67 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | 7 years |
| Felix Baker | M | 55 | 20 years | |
| Cynthia Shumate | F | 62 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 7 years |
| Charles Romp | M | - | 13 years | |
| Nancy Simonian | M | 63 | 11 years | |
| Roger Dansey | M | 68 | 5 years | |
| Alpna Seth | M | 60 | 5 years | |
| Srini Akkaraju Akkaraju | M | 56 | 17 years | |
| Eric Dobmeier | M | 55 | 16 years | |
| John Orwin | M | 62 | 9 years | |
| Eric Sievers | M | 60 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 12 years |
| Kirk D. Schumacher | M | - | 11 years | |
| David Epstein | M | 62 | 1 years | |
| James Kyle Bryan | M | - | - | |
| Christopher Boerner | M | 53 | 5 years | |
| Sandra Swain | M | 70 | 1 years | |
| Daniel Welch | M | 66 | 17 years | |
| Darren Cline | M | 59 | 9 years | |
| John McLaughlin | M | 72 | 9 years | |
| David Gryska | M | 68 | 18 years | |
| Martin Mattingly | M | 66 | 13 years | |
| Franklin Berger | M | 74 | 10 years | |
| Suzanne M. Shema | F | 66 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 8 years |
| Jean Liu | F | 55 | 9 years | |
| Donald Joseph | M | 70 | 6 years | |
| Thomas Reynolds | M | 65 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 11 years |
| Steven Reed | M | 73 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 10 years |
| Jay Moyes | M | 70 | 6 years | |
| Ted Love | M | 65 | 3 years | |
| Marc Lippman | M | 79 | 22 years | |
| Chao Hong Hu | M | 58 | 6 years | |
| Vlad Popovic | M | - | 4 years | |
| Stanford Peng | M | 53 | 1 years | |
| Charles Sang | M | 56 | 2 years | |
| Dennis Benjamin | M | - | 3 years | |
| Tina Albertson | M | 51 | 5 years | |
| Eric Feldman | M | 68 | 3 years | |
| David Fontana | M | - | - | |
| Robert Lechleider | M | - | 4 years | |
| Naomi Hunder | M | 54 | 7 years | |
| Leslie Aberman | F | - | 8 years | |
| Robin Taylor | M | - | 1 years | |
| Tuomo Tapani Pätsi | M | 60 | - | |
| Neil Josephson | M | - | 6 years | |
| Dennis Cho | M | 53 | 2 years | |
| Bruce J. Seeley | M | 59 | 3 years | |
| Jonathan Drachman | M | 62 | 14 years | |
| Michael J. Dwyer | M | 68 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 3 years |
| Daniel F. Hoth | M | 78 | 4 years | |
| Joseph M. Davie | M | 84 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | - |
| David H. Persing | M | 67 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 6 years |
| Jan Öhrström | M | 67 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 7 years |
| Michelle Burris | F | 58 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 11 years |
| Morris Z. Rosenberg | M | 64 | 8 years | |
| Russell Hawkinson | M | 65 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 10 years |
| Brandi Robinson | F | - | 2 years | |
| Monica Krieger | M | 75 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 6 years |
| Ron Myers | M | - |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | - |
| Gregory R. Cox | M | 58 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 10 years |
| Elaine Waller | M | 72 | 10 years | |
| Elizabeth Bekiroglu | F | 54 | 5 years | |
| Stanford J. Stewart | M | 71 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | 4 years |
| Jorge Cerda Lucero | M | - | - | |
| Samuel Yonren | M | - | - | |
| Gabriel Luciano | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 88 | 88.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Vaughn Himes
- Personal Network